Dietary Supplements and Diets Show No Impact on Cardiovascular Risk

Americans spend billions in dietary supplements every year but, in truth, this money is only wasted, according to evidence form a recent study published in Intern Med.

Nuevas alternativas prometedoras para la insuficiencia mitral

Most of dietary interventions and nutritional supplements including multi-vitamins, selenium and antioxidants, do not reduce cardiovascular risk or mortality, according to this large analysis and systematic revision of several randomized studies.

Modest benefits were indeed observed when reducing salt consumption and when incorporating omega 3 polyunsaturated fatty acids and folic acid.

On the other hand, combining calcium and vitamin D seems to increase stroke risk.

However, despite different guidelines and societies claim the evidence behind these recommendations is insufficient, one every other American consume some sort of vitamin or dietary supplement, and the proportion increases with age.


Read also: Supervised Exercise and Revascularization for Intermittent Claudication.


In this context, researchers wanted to provide quality evidence by testing the effect of nutritional supplements and, to this end, included 9 systematic reviews and 4 randomized studies with nearly one million participants. Data included studies VITAL and ASCEND, which studied the impact of vitamin D and omega-3.

Globally, they were able to find certain evidence that reduced salt consumption has a modest positive effect on global mortality in persons with normal blood pressure (RR 0.90; 95% CI 0.85-0.95) and a more significant positive effect on cardiovascular mortality in hypertensives (RR 0.67; 95% CI 0.46-0.99).

Additionally, “low certainty” evidence suggested omega-3 acids reduce the risk of infarction and heart disease.

There was also “low certainty” evidence that folic acid reduced stroke risk, though this benefit was driven basically by one single study conducted in China.


Read also: Many Guidelines, Much Confusion. Blood Pressure Targets in the Elderly.


Finally, and with “moderate certainty”, calcium and vitamin D supplements would increase stroke risk (RR 1.17; 95% CI 1.05-1.30).

No other supplement, including vitamins A, B complex, C, D or E, antioxidants, iron or other dietary interventions (including reduced fat intake) impact mortality or cardiovascular events, neither positively nor negatively.

Most people are wasting their money in vitamins, buying supplements at the pharmacy, when it would be more sensible, rational and a lot cheaper to buy vitamins at the groceries’.

Most surprisingly, the “Mediterranean diet” showed no impact, seeing as the PREDIMED outcomes suggest the benefit of diets rich in vegetables, whole grains, nuts and olive oil. Researchers speculate these results might have been counterbalanced with other study results with null outcomes.

Original title: Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: an umbrella review and evidence map.

Reference: Khan SU et al. Ann Intern Med. 2019;171:190-198.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...